Logo image of ADOC.PA

ADOCIA SAS (ADOC.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ADOC - FR0011184241 - Common Stock

6.36 EUR
-0.05 (-0.78%)
Last: 12/24/2025, 7:00:00 PM
Fundamental Rating

2

ADOC gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 82 industry peers in the Biotechnology industry. ADOC has a bad profitability rating. Also its financial health evaluation is rather negative. ADOC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ADOC has reported negative net income.
In the past year ADOC has reported a negative cash flow from operations.
In the past 5 years ADOC always reported negative net income.
In the past 5 years ADOC always reported negative operating cash flow.
ADOC.PA Yearly Net Income VS EBIT VS OCF VS FCFADOC.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

ADOC's Return On Assets of -36.00% is in line compared to the rest of the industry. ADOC outperforms 42.68% of its industry peers.
Industry RankSector Rank
ROA -36%
ROE N/A
ROIC N/A
ROA(3y)-47.02%
ROA(5y)-53.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ADOC.PA Yearly ROA, ROE, ROICADOC.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200

1.3 Margins

The Gross Margin of ADOC (79.22%) is better than 68.29% of its industry peers.
The Profit Margin and Operating Margin are not available for ADOC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 79.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ADOC.PA Yearly Profit, Operating, Gross MarginsADOC.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

More info and screens

2

2. Health

2.1 Basic Checks

ADOC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ADOC has been increased compared to 1 year ago.
Compared to 5 years ago, ADOC has more shares outstanding
Compared to 1 year ago, ADOC has an improved debt to assets ratio.
ADOC.PA Yearly Shares OutstandingADOC.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ADOC.PA Yearly Total Debt VS Total AssetsADOC.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -0.20, we must say that ADOC is in the distress zone and has some risk of bankruptcy.
ADOC's Altman-Z score of -0.20 is in line compared to the rest of the industry. ADOC outperforms 48.78% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.2
ROIC/WACCN/A
WACC7.65%
ADOC.PA Yearly LT Debt VS Equity VS FCFADOC.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

ADOC has a Current Ratio of 1.15. This is a normal value and indicates that ADOC is financially healthy and should not expect problems in meeting its short term obligations.
ADOC has a Current ratio of 1.15. This is in the lower half of the industry: ADOC underperforms 71.95% of its industry peers.
A Quick Ratio of 1.14 indicates that ADOC should not have too much problems paying its short term obligations.
ADOC's Quick ratio of 1.14 is on the low side compared to the rest of the industry. ADOC is outperformed by 68.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 1.14
ADOC.PA Yearly Current Assets VS Current LiabilitesADOC.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

4

3. Growth

3.1 Past

ADOC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.36%, which is quite impressive.
ADOC shows a strong growth in Revenue. In the last year, the Revenue has grown by 1879.16%.
ADOC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 34.18% yearly.
EPS 1Y (TTM)63.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.42%
Revenue 1Y (TTM)1879.16%
Revenue growth 3Y86.19%
Revenue growth 5Y34.18%
Sales Q2Q%N/A

3.2 Future

ADOC is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -36.12% yearly.
ADOC is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -18.00% yearly.
EPS Next Y-90.2%
EPS Next 2Y-42.41%
EPS Next 3Y-28.13%
EPS Next 5Y-36.12%
Revenue Next Year-51.75%
Revenue Next 2Y-37.38%
Revenue Next 3Y-50%
Revenue Next 5Y-18%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ADOC.PA Yearly Revenue VS EstimatesADOC.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M
ADOC.PA Yearly EPS VS EstimatesADOC.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2 4 6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ADOC. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ADOC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ADOC.PA Price Earnings VS Forward Price EarningsADOC.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ADOC.PA Per share dataADOC.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

ADOC's earnings are expected to decrease with -28.13% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-42.41%
EPS Next 3Y-28.13%

More info and screens

0

5. Dividend

5.1 Amount

ADOC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

ADOCIA SAS

EPA:ADOC (12/24/2025, 7:00:00 PM)

6.36

-0.05 (-0.78%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-15 2025-10-15
Earnings (Next)04-15 2026-04-15/amc
Inst Owners7.95%
Inst Owner ChangeN/A
Ins Owners3.79%
Ins Owner ChangeN/A
Market Cap116.45M
Revenue(TTM)10.35M
Net Income(TTM)-9.72M
Analysts84.44
Price Target15.5 (143.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.51%
PT rev (3m)8.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)14.47%
EPS NY rev (3m)-67.6%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.25
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.56
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)-0.85
FCFYN/A
OCF(TTM)-0.83
OCFYN/A
SpS0.57
BVpS-0.05
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -36%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 79.22%
FCFM N/A
ROA(3y)-47.02%
ROA(5y)-53.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 40%
Cap/Sales 2.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.15
Quick Ratio 1.14
Altman-Z -0.2
F-Score4
WACC7.65%
ROIC/WACCN/A
Cap/Depr(3y)32.53%
Cap/Depr(5y)29.18%
Cap/Sales(3y)3.75%
Cap/Sales(5y)12.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.42%
EPS Next Y-90.2%
EPS Next 2Y-42.41%
EPS Next 3Y-28.13%
EPS Next 5Y-36.12%
Revenue 1Y (TTM)1879.16%
Revenue growth 3Y86.19%
Revenue growth 5Y34.18%
Sales Q2Q%N/A
Revenue Next Year-51.75%
Revenue Next 2Y-37.38%
Revenue Next 3Y-50%
Revenue Next 5Y-18%
EBIT growth 1Y47.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-75.21%
EBIT Next 3Y-29.09%
EBIT Next 5YN/A
FCF growth 1Y-33.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.9%
OCF growth 3YN/A
OCF growth 5YN/A

ADOCIA SAS / ADOC.PA FAQ

What is the fundamental rating for ADOC stock?

ChartMill assigns a fundamental rating of 2 / 10 to ADOC.PA.


Can you provide the valuation status for ADOCIA SAS?

ChartMill assigns a valuation rating of 0 / 10 to ADOCIA SAS (ADOC.PA). This can be considered as Overvalued.


Can you provide the profitability details for ADOCIA SAS?

ADOCIA SAS (ADOC.PA) has a profitability rating of 1 / 10.


How financially healthy is ADOCIA SAS?

The financial health rating of ADOCIA SAS (ADOC.PA) is 2 / 10.